Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 29;352(6285):550-5.
doi: 10.1126/science.aad4821.

Changes in the composition of brain interstitial ions control the sleep-wake cycle

Affiliations

Changes in the composition of brain interstitial ions control the sleep-wake cycle

Fengfei Ding et al. Science. .

Abstract

Wakefulness is driven by the widespread release of neuromodulators by the ascending arousal system. Yet, it is unclear how these substances orchestrate state-dependent, global changes in neuronal activity. Here, we show that neuromodulators induce increases in the extracellular K(+) concentration ([K(+)]e) in cortical slices electrically silenced by tetrodotoxin. In vivo, arousal was linked to AMPA receptor-independent elevations of [K(+)]e concomitant with decreases in [Ca(2+)]e, [Mg(2+)]e, [H(+)]e, and the extracellular volume. Opposite, natural sleep and anesthesia reduced [K(+)]e while increasing [Ca(2+)]e, [Mg(2+)]e, and [H(+)]e as well as the extracellular volume. Local cortical activity of sleeping mice could be readily converted to the stereotypical electroencephalography pattern of wakefulness by simply imposing a change in the extracellular ion composition. Thus, extracellular ions control the state-dependent patterns of neural activity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Neuromodulators increase [K+]e concentration in the absence of neuronal activity. (A) Representative traces of [K+]e shifts before, during, and after administering the neuromodulator cocktail. Scale bar: x = 5 min, y = 0.2 mM [K+]e (B) 30 s binned averages of shifts before and after neuromodulator cocktail (C and D) Summary of [K+]e increase following neuromodulator cocktail application in slices ± TTX (paired t-test, C (-TTX): t(11) = 5.871, P = 0.0001; D (+TTX), t(21) = 11.69, P < 0.0001). Inset: representative fEPSP recordings before and after application of TTX. Scale bar = 10 ms (E) Summarized shifts at 10 minutes following changing perfusion solution. n = 6 (cocktail-free aCSF), 12 (cocktail), 10 (aCSF+TTX), 22 (cocktail+TTX). One-way ANOVA: F(3,46) = 25.94, P < 0.0001. Post-hoc Tukey test: ** P < 0.01, ***P < 0.001. (F) Representative trace of large [K+]e spike following metabolic stress using iodoacetate (IA). Trace includes pre-cocktail baseline, aCSF + cocktail, aCSF + IA and return to baseline aCSF. (Right) Magnified trace showing [K+]e increases in slices treated with the neuromodulator cocktail (±TTX) followed by IA. Scale bars: x = 5 min, y = 0.2 mM [K+]e. Mean (black circle) ± SEM.
Fig. 2
Fig. 2
Extracellular K+ is higher during wakefulness. (A and B) Representative ECoG, [K+]e, and EMG recordings with a data summary of state transitions in sleep to awake (A) or awake to sleep (B) Initial [K+]e concentrations are shown to the left, and the 1–4 Hz power is displayed above to illustrate state-dependent shifts, binned at 10 s for clarity. n = 34 transitions; One-way, repeated measures ANOVA: F(3,99) = 9.536, P < 0.0001. Tukey post-hoc multiple comparisons test: ***P < 0.001. Scale bar: x = 20 s, y = 0.1 mM [K+]e; ECoG = 0.75 mV; EMG = 0.3 mV (A), 1 mV (B). (C) Representative recording of awake to isoflurane transitions recorded during the natural awake period (ZT16-20). n = 11 animals. One-way repeated measures ANOVA: F(2,20) = 35.61, P < 0.0001. Post-hoc Tukey test: ***P < 0.001. Scale bar: x = 1.5 min, y = 0.15 mM [K+]e, 0.75 mV EMG and ECoG. (D) Microdialysis samples collected from freely moving mice during their awake (ZT14-20) or sleeping (ZT2-8) period, and under isoflurane anesthesia. (Left) Schematic illustrating setup and inflow [K+] gradient with representative ISM trace and sample no-net flux method plot used for [K+]e estimate. (right) Summary of [K+]e by state: n = 12 awake, 12 sleep, and 13 isoflurane animals. One-way ANOVA: F(2, 34) = 8.055, P = 0.0014. Post-hoc Tukey test: *P <0.05, **P < 0.01. (E) Comparison of all state-dependent transitions. One-way ANOVA comparing mean shifts by group: F(5,161) = 16.61, P < 0.0001. Post-hoc Tukey test: *P < 0.05, **P < 0.01. Mean (black circle) ± SEM
Fig. 3
Fig. 3
Extracellular Ca2+ decreases during wakefulness. (A and B) Representative ECoG, EMG, and [Ca2+]e recordings in sleep to awake (A) and awake to sleep (B). Initial [Ca2+]e is listed to the left with 1–4 Hz power presented above. n = 28 transitions. One-way, repeated measures ANOVA: F(3,81) = 39.91, P < 0.0001. Post-hoc Tukey test: ***P < 0.001. Scale bars: x = 20 s (A), 40 s (B), y: [Ca2+]e = 0.05 mM, 0.75 mV EMG/ECoG (C) Representative recording of isoflurane induction and recovery (ZT16-20) and data summary. n = 11 animals. One-way repeated measures ANOVA: F(2,20) = 18.52, P < 0.0001. Post-hoc Tukey test: ***P < 0.001. Scale bar: x = 6 min, y = [Ca2+]e = 0.2 mM, 0.5 mV EMG/ECoG. (D) Schematic of microdialysis collection. Individual sleep (light blue) and awake (gray) data are pooled and compared to isoflurane. n = 8 awake, 8 sleep, and 8 isoflurane. Two-tailed t-test of isoflurane versus non isoflurane: t(22) = 3.420, P = 0.003. **P < 0.01. (E) Comparisons of [Ca2+]e shifts from the awake to sleep, isoflurane, CNQX and CNQX + isoflurane. n =8 animals CNQX and CNQX + Isoflurane One-way ANOVA comparison of state-dependent shifts: F(4,117) = 5.824, P = 0.0003; Post-hoc Tukey test: *P < 0.05, **P < 0.01. Mean (black circle) ± SEM.
Fig. 4
Fig. 4
Extracellular Mg2+ decreases during wakefulness. (A and B) Representative state-transitions between sleep and awake ECoG, EMG, and Mg2+-sensitive microelectrodes with data summary. Initial [Mg2+]e is given to the left of the ISM trace. n = 73 sleep to awake transitions (A) and 58 awake to sleep transitions (B). One-way ANOVA: F(3, 258) = 28.13, P < 0.0001. Post-hoc Tukey test: ***P < 0.001. Scale bars: x = 20 s, y = 0.05 mM [Mg2+]e, 0.33 mV EMG/ECoG. (C) Representative awake to isoflurane recording (ZT16-20) and summary of changes. n = 11 animals. One-way repeated measures ANOVA: F(2,20) = 28.13, P < 0.0001. Post-hoc Tukey test: *P < 0.05, ***P < 0.001. Scale bar: x = 5 minutes, y = 0.25 mM [Mg2+]e, 0.6 mV EMG/ECoG. (D) Schematic of microdialysis collection with data summary. Representative Mg2+-ISM and no-net flux calculation are shown. Sleep (light blue) and awake (gray) are pooled and compared to isoflurane. n = 8 awake, 8 sleep, and 8 isoflurane. Two-tailed t-test of isoflurane versus pre-isoflurane: t(16) = 2.427, P = 0.0274. (*P < 0.05). (E) Comparison of state-dependent [Mg2+]e shifts from awake to sleep, isoflurane, CNQX and awake + CNQX to isoflurane + CNQX. n = awake to CNQX: 6 animals; awake + CNQX to isoflurane + CNQX: 6 animals. One-way ANOVA of relative state-dependent shifts: F(4,167) = 27.31, P < 0.0001. Post-hoc Tukey test: **P < 0.01, ***P < 0.001. Mean (black circle) ± SEM.
Fig. 5
Fig. 5
Imposing changes in extracellular ion concentrations alter local activity, extracellular space, and behavioral state. (A) Schematic of double-cranial window recording setup. Symmetrically positioned, separate cranial windows over opposing somatosensory cortices were prepared with ECoGs simultaneously recorded in both hemispheres. (B and C) Representative ECoG recordings in B sleeping (ZT4-8), and C awake (ZT16-20) mice. (top) Representative recordings in aCSF mimicking natural state-dependent interstitial ion composition. (bottom) Recordings following change of left hemisphere aCSF to awake-inducing (B) or sleep-inducing aCSF (C) (right) Summary of 1–4 Hz ECoG power shift in the left hemisphere, normalized to the right, following change to awake-inducing (B) or sleep-inducing (C) aCSF. (paired t-test of 1–4 Hz power shifts: A: t(8) = 3.530, P = 0.008; B: t(6) = 3.091, P = 0.0214)). *P < 0.05, **P < 0.01. Scale bar: x = 4 min, y = 10% (D) TMA+ traces of shifts in extracellular space volume (α) following switch from sleep to awake-inducing aCSF (upper trace) or awake to sleep-inducing aCSF (lower trace) Note: higher amplitude = decreased dilution of TMA+, and smaller extracellular space. Data are summarized to the right. Paired t-test (awake-inducing: n = 16 animals; t(15) = 11.04, P < 0.0001; sleep-inducing: n = 11 animals; t(10) = 8.95, P < 0.0001 ) **P < 0.01. Scale: x = 2 min, y = 2 mV. (E) Schematic of cisterna-magna infusion and wire EEG/EMG recording setup. (F and G) Representative traces showing EEG and EMG activity prior, during, and following a 0.3–0.5 μl min−1 infusion of modified awake-inducing (F) or sleep-inducing (G) aCSF into the cisterna magna. The 1–4 Hz relative power (% of 1–32 Hz) is presented in averaged 10 min bins below. Infusion was run between ZT 5.5-7 (gray bar) (F) and ZT15-16.5 (purple bar) (G), during sleep and awake periods, respectively. Scale bar: x = 30 min, y = 0.5 mV (F), 1mV (G).

Comment in

References

    1. Tononi G, Cirelli C. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron. 2014;81:12–34. - PMC - PubMed
    1. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol. 1995;45:347–360. - PubMed
    1. Hinard V, et al. Key electrophysiological, molecular, and metabolic signatures of sleep and wakefulness revealed in primary cortical cultures. J Neurosci. 2012;32:12506–12517. - PMC - PubMed
    1. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437:1257–1263. - PubMed
    1. O’Donnell J, Zeppenfeld D, McConnell E, Pena S, Nedergaard M. Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res. 2012;37:2496–2512. - PMC - PubMed

Publication types

MeSH terms